Amdocs Limited (DOX)
NASDAQ:DOX
Want to see DOX full AI Analyst Report?
DOX Stock Chart & Stats
$67.63
-$0.67(-0.80%)
At close: 4:00 PM EST
$67.63
-$0.67(-0.80%)
Day’s Range― - ―
52-Week Range$55.27 - $95.41
Previous CloseN/A
Volume115.06K
Average Volume (3M)1.17M
Market Cap
$6.07B
Enterprise Value$7.63B
Total Cash (Recent Filing)$214.50M
Total Debt (Recent Filing)$1.07B
Price to Earnings (P/E)11.0
Beta0.60
Next Earnings
Aug 12, 2026EPS Estimate
1.85Next Dividend Ex-DateN/A
Dividend Yield2.57%
Share Statistics
EPS (TTM)5.03
Shares Outstanding107,571,000
10 Day Avg. Volume1,299,003
30 Day Avg. Volume1,170,386
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)2.66
Price to Sales (P/S)2.01
P/FCF Ratio14.14
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue1.65
Enterprise Value/Gross Profit4.42
Enterprise Value/Ebitda8.09
Forecast
1Y Price Target
$74.50Price Target Upside10.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)7.46
Revenue Forecast (FY)$4.69B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash FlowAmdocs generates robust free cash flow (TTM ~$679M, ~86% of net income). This durable cash generation supports reinvestment in products, multi-year managed-service delivery, share buybacks and dividends while providing a buffer during project timing volatility and economic cycles.
Conservative Balance SheetThe company maintains modest leverage with equity (~$3.38B) and manageable debt levels (D/E ~0.24–0.32). This structural strength preserves financial flexibility to fund cloud modernization programs, make selective acquisitions, and absorb cyclical project timing without threatening solvency.
Backlog And Strategic Product PipelineA sizable twelve‑month backlog (~$4.28B) gives multi‑quarter revenue visibility from transformation programs. Concurrently, launching aOS and early commercial wins signal a strategic shift toward automation/agentic offerings that can deepen telco relationships and create higher‑margin, recurring revenue over the medium term.
Bears Say
Modest Organic GrowthTop-line expansion is modest on an organic basis (≈2.2% CC), with management indicating roughly half of expected FY growth will come from inorganic sources. Dependence on acquisitions or tuck‑ins to hit growth targets raises execution and integration risk and may obscure core demand trends.
Early-stage Product MonetizationWhile aOS represents a strategic direction, commercial traction remains nascent and revenue contribution is currently immaterial. The time and investment required to scale agentic/GenAI offerings into sustained, material revenue creates execution and timing risk for anticipated margin and growth benefits.
Rising Borrowings And Interest CostsNet borrowings have increased (~$900M aggregate) and management expects higher net interest expense from short‑term borrowing. Rising financing costs and a lower cash balance reduce cushion for investment or buybacks and can pressure net margins if rates remain elevated.
Amdocs News
DOX FAQ
What was Amdocs Limited’s price range in the past 12 months?
Amdocs Limited lowest stock price was $55.27 and its highest was $95.41 in the past 12 months.
What is Amdocs Limited’s market cap?
Amdocs Limited’s market cap is $6.07B.
When is Amdocs Limited’s upcoming earnings report date?
Amdocs Limited’s upcoming earnings report date is Aug 12, 2026 which is in 57 days.
How were Amdocs Limited’s earnings last quarter?
Amdocs Limited released its earnings results on May 13, 2026. The company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.768 by $0.012.
Is Amdocs Limited overvalued?
According to Wall Street analysts Amdocs Limited’s price is currently Undervalued.
Does Amdocs Limited pay dividends?
Amdocs Limited pays a Quarterly dividend of $0.569 which represents an annual dividend yield of 2.57%. See more information on Amdocs Limited dividends here
What is Amdocs Limited’s EPS estimate?
Amdocs Limited’s EPS estimate is 1.85.
How many shares outstanding does Amdocs Limited have?
Amdocs Limited has 107,571,000 shares outstanding.
What happened to Amdocs Limited’s price movement after its last earnings report?
Amdocs Limited reported an EPS of $1.78 in its last earnings report, beating expectations of $1.768. Following the earnings report the stock price went up 3.337%.
Which hedge fund is a major shareholder of Amdocs Limited?
Currently, no hedge funds are holding shares in DOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Amdocs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$74.50 (10.16% Upside)
$74.50 (10.16% Upside)
Blogger Sentiment
Bullish
DOX Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $29.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.4%
Last 30 Days ▼ 8.2%
Last 30 Days ▼ 8.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.37%
12-Months-Change
Fundamentals
Return on Equity
15.91%
Trailing 12-Months
Asset Growth
2.57%
Trailing 12-Months
Company Description
Amdocs Limited
Amdocs Limited is a global provider of software solutions and associated services, operating through its various subsidiaries worldwide. The company is actively involved in the full lifecycle of its cloud-based portfolio, from designing and developing to operating, implementing, supporting, and marketing these open and modular offerings. Its diverse product lineup includes CES21, a leading customer experience suite built on 5G and cloud-native microservices architecture, which empowers service providers to develop, deliver, and monetize advanced services. Amdocs also offers a Commerce and Care suite for streamlining order processing and customer engagement, and a Monetization suite that handles charging, billing, policy enforcement, and overall revenue management. Further offerings include an Intelligent Networking suite, providing modular, flexible, and open service lifecycle management capabilities for network automation; MarketONE, a cloud-native business ecosystem; the Digital Brands Suite, a pre-integrated digital business platform tailored for emerging digital telecom brands and smaller service providers; and the eSIM Cloud for service providers. Beyond these core products, Amdocs furnishes AI-powered, cloud-native home operating systems, various data intelligence solutions, and applications. The company also extends its expertise to media services for publishers, TV networks, and video streaming providers, along with end-to-end application development and maintenance services and continuous operational support. Amdocs provides an extensive array of services that cater to every stage of a service provider's lifecycle. These encompass design, delivery, quality engineering, operations, systems integration, mobile network services, expert consulting, and content services. Additionally, its managed services segment covers application development, modernization, and maintenance, IT and infrastructure support, testing, and professional services, all designed to assist clients in the selection, implementation, operation, management, and upkeep of their IT systems. The company's clientele primarily consists of service providers across the communications, cable and satellite, entertainment, and broader media industries, alongside mobile virtual network operators (MVNOs) and directory publishers. Amdocs Limited was established in 1988 and maintains its corporate headquarters in Saint Louis, Missouri.
DOX Company Deck
DOX Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a constructive, growth-oriented tone: Amdocs reported revenues and EPS above guidance midpoints, delivered regional strengths (record Europe quarter, RoW growth), improved YoY operating margin, generated strong free cash flow and announced strategic product (aOS) launches and initial customer wins. Challenges include modest organic growth, early-stage aOS monetization, incremental financing costs due to lower cash and borrowings, and quarter-to-quarter project timing volatility. Management reiterated guidance, increased investment in GenAI/aOS, and emphasized liquidity and capital return plans. On balance the positive operational results, strong cash generation, backlog growth and clear strategic direction around agentic/GenAI initiatives outweigh the listed near-term headwinds.View all DOX earnings summariesDOX Stock 12 Month Forecast
Average Price Target
$74.50
▲(10.16% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
26.65% Mutual Funds
37.44% Other Institutional Investors
26.48% Public Companies and
Individual Investors